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Our usual practice is to consider reoperation on the basis
of the patient’s current medical condition in symptom-free
patients with restenosis > 80%.
A low perioperative morbidity rate and a low incidence of
recurrent stenosis are vital to make CEA a statistically worth-
while procedure. A technically excellent repair is needed to
achieve this result. Intraoperative completion carotid evalua-
tion has been advocated to maximize the quality of recon-
struction and reduce residual stenosis.9,10 Perioperative
neurologic deficits have been correlated with intraoperative
technical errors.5 An increased incidence of late stenosis has
been noted where abnormalities on intraoperative duplex
study have been left unrepaired.3 Preliminary studies have
suggested that the need for perioperative duplex study after
CEA with an intraoperative completion study is not only
unnecessary, but may show increased abnormalities without
increased risk of future stroke.11
With growing concern over and limitations on medical
costs, it has become necessary to optimize duplex scan sur-
veillance while still maintaining good patient care and
minimizing future stroke risk. To this end, we have evalu-
ated the need for duplex surveillance scans within the first
6 months after CEA with intraoperative completion study.
METHODS
Patients. A total of 647 CEAs were performed at
UCLA between July 1989 and June 1999, excluding
Carotid endarterectomy (CEA) is the established
treatment of choice for both symptomatic and asymp-
tomatic high-grade carotid stenosis. After CEA, the risk of
stroke is lowered, and overall mortality is decreased.
Residual and recurrent stenosis rates of 4% to 22% have
been reported in postoperative duplex scans.1,2 Although
the ramifications of recurrent stenosis are controversial,
restenosis < 75% seems to carry a low risk of stroke, and
many early lesions undergo regression.3,4 Restenosis >
75% has been associated with increased risk of late
stroke.5,6 To this end, early postoperative duplex scan fol-
low-up has been recommended within the first 1 to 2
months after CEA and again at 1 year.7,8 In fact, a stan-
dard practice of many clinicians is to obtain an early post-
operative duplex scan and then repeat duplex scans at 6
months and 1 year. This has been our protocol at UCLA.
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Objective: The objective of this study was to determine the value of early (< 6 months) duplex scanning after carotid
endarterectomy (CEA) with an intraoperative completion study with normal results. Attention was paid to restenosis
rates and reoperation for recurrent stenosis within the first 6 months.
Methods: A retrospective review was performed on 380 CEAs (338 patients) with intraoperative completion studies and
duplex surveillance within the first 6 months. Results of completion studies, restenosis rates, and recurrent symptoms
were evaluated for each operation. Studies were performed from 0 to 200 days postoperatively (median, 28).
Results: Intraoperative completion studies included 333 angiograms, 26 duplex scans, and 21 angiograms with duplex
scans. Of the 380 intraoperative completion studies, 28 (7.5%) had abnormal findings, including 14 abnormal inter-
nal carotid arteries (ICAs). Twenty-four procedures were revised, and the findings of all repeat completion studies were
normal. Of the initial completion studies, in four cases, abnormalities (3 ICAs) were insignificant and did not warrant
further intervention. Follow-up ICA duplex scans had normal results after 364 (95.8%) CEAs. There were 14 mild
recurrent ICA stenoses and two moderate recurrent ICA stenoses; neither had abnormal findings from the completion
study. There were no severe recurrent ICA stenoses. External carotid artery (ECA) recurrent stenosis included 7 mild,
15 moderate, and 9 severe restenoses.
Conclusions: Only 0.5% of CEAs developed moderate restenosis. No procedures had severe recurrent stenosis on duplex
scan within the first 6 months, and none required intervention. Duplex surveillance in the first 6 months is relatively
unproductive, providing that there were normal results from an intraoperative completion study for each patient.
Routine surveillance can be started at 1 year. (J Vasc Surg 2001;33:963-7.)
patients undergoing combined CEA with coronary artery
bypass grafting. Of the CEAs performed, 380 CEAs (59%)
were performed with intraoperative completion studies
and duplex surveillance within the first 6 months (264
patients did not have a duplex scan study within the first 6
months at UCLA, and 3 patients did not receive an intra-
operative completion study). These 380 CEAs were per-
formed on 338 patients (some patients underwent CEA
on the contralateral side or repeat CEA on the same side).
The mean age of the patients was 70.4 years (range, 41-92
years). Patient characteristics are summarized in the Table.
All the patients underwent preoperative carotid evalua-
tion. A total of 377 patients (99%) underwent CEA on the
basis of only a preoperative duplex scan.
Operative management. A total of 377 CEAs were
performed with patients under general endotracheal anes-
thesia, whereas three were performed with the patients
under local anesthesia. The procedures were performed
with shunt in 127 cases (33%). Brain mapping was used to
monitor patients in 365 cases (96%), stump pressures were
measured in 3 cases (1%), and no monitoring was per-
formed in 10 cases (3%). Changes requiring shunt place-
ment were noted in 76 procedures. In all cases where no
monitoring was performed a shunt was placed. Forty-one
patients were shunted because of recent stroke or
crescendo transient ischemic attacks (TIAs). Primary clo-
sure was performed in 63 cases. Patch angioplasty was per-
formed in 317 cases, with 311 prosthetic patches, 5 vein
patches, and 1 arterial patch. A total of 303 woven poly-
ester fiber (Dacron) patches were used, while only 11
polytetrafluoroethylene patches were used.
Anticoagulation of aspirin and heparin was used.
Unless contraindicated, aspirin was started preoperatively.
A single dose of heparin was given in the operating room
and not reversed.
Intraoperative completion studies. Completion stud-
ies were performed to evaluate the entire endarterectomized
carotid including the external carotid artery (ECA).
Angiograms were performed in the following manner: C-
arm fluoroscopy was used to obtain and store angiogram
images. A 10-cc syringe attached to a straight intravenous
extension tube with 20- to 22-gauge needle was placed into
the common carotid artery proximal to the endarterec-
tomized site. Hand injection of intravenous contrast was
made with flow up both the internal and external carotid
arteries. In most cases, a single injection was sufficient.
Completion studies included intraoperative angiogram in
333 cases, duplex scan in 26 cases, and both intraoperative
angiogram and duplex scan in 21 cases. Intraoperative com-
pletion studies (n = 380) were interpreted as normal in 352
cases (93%) and abnormal but minor in four cases (1%).
Significant abnormalities were found in 24 cases (6%).
Results of 28 of the 380 completion studies were abnormal,
including 14 abnormal internal carotid arteries (ICAs) and
14 ECAs. Thirteen ICAs and 11 ECAs were revised, and the
results of all repeat completion studies were normal. In four
cases (3 ICAs) abnormalities were minor and did not war-
rant further intervention. All significant abnormalities
underwent immediate revision, and normal results were
found on repeat completion study.
Postoperative surveillance. Duplex surveillance was
performed from one to four times within the first year after
each CEA (mean, 2 ± 0.8; median, 2). Studies were per-
formed from 0 to 475 days postoperatively (mean, 141 ±
26). For evaluation purposes, duplex scans were divided
into two groups: those performed in the first 6 months (0-
200 days; mean, 31 ± 25) postoperatively and those per-
formed in the second 6 months (200-475 days; mean, 376
± 75) postoperatively. Duplex scans were graded as normal
(0%), mild restenosis (1%-59%), moderate restenosis (60%-
79%), and severe restenosis (> 80%). Differentiation of nor-
mal and minimal disease was based on gray-scale image.
The primary diagnostic criterion was the ratio of peak ICA
to CCA velocity. The cut point for 60% stenosis was 1.9 and
for 80% was 3.7. No flow was deemed as 100% stenosis.
This study did not evaluate for contralateral disease.
Obviously, careful follow-up of the contralateral side is
needed. In general, 6-month duplex follow-up of the non-
operative side is obtained when stenosis is > 60%.
Complications. Perioperative events included all
complications within the first 30 days. All other complica-
tions were considered long term. Perioperative symptoms
and long-term symptoms included strokes and TIAs, and
they were evaluated for the operative carotid distribution.
The records specifically identified patients who had neu-
rologic complications or who died, but because the study
focused on early results, long-term follow-up was not
recorded in our patients without complications.
RESULTS
Perioperative events. A total of 332 patients had no
complications within the first 30 days (88%). Four periop-
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Patient background
No. Percent
Total patients in study 338








Amaurosis fugax 54 14%
Stroke 50 13%
Preoperative evaluation






MRA, Magnetic resonance angiography; TIA, transient ischemic attack.
erative strokes (1%) occurred, and all were ipsilateral. Of
these patients with perioperative strokes, one was symp-
tom free before surgery, two had TIAs before surgery, and
one had a minor stroke before surgery. Results of comple-
tion studies in these patients were normal, no patients had
revisions at the time of operation, and none had recurrent
stenosis with duplex scan on follow-up examination within
the first 6 months. Two perioperative TIAs (0.5%)
occurred. Completion studies had normal results in these
two patients, and neither had revision during the time of
operation. Also, neither had recurrent stenosis with duplex
scan on follow-up examination within the first 6 months.
No deaths occurred. Two patients had acute myocar-
dial infarctions. Four patients (1%) had new onset conges-
tive heart failure. Two patients (0.5%) had new onset
hypertension. Five patients (1%) had severe hypotension
that required more treatment than rehydration. Sixteen
patients (4%) had wound complications including two
(0.5%) infections and 14 (3%) hematomas requiring reop-
eration. Nine patients (2%) had temporary cranial nerve
XII injury. One patient had a postoperative seizure. Two
patients (0.5%) had acute renal failure. Two patients
(0.5%) had respiratory distress requiring emergency rein-
tubation. The respiratory distress in these two patients was
primary respiratory distress; it was not due to neck
hematomas. No new onset hypertension was noted post-
operatively.
Long-term symptoms and events. Ten deaths were
reported. None were due to stroke, and none occurred
within the first year. Two ipsilateral strokes (0.5%) and two
ipsilateral TIAs (0.5%) occurred between 1 month and a
year postoperatively. None of these patients had recurrent
stenosis on duplex scan. After the first year, 10 ipsilateral
strokes (3%) occurred, of which three had recurrent steno-
sis > 80%. Seven strokes (2%) outside the operated carotid
distribution occurred. TIAs occurred in 31 patients (8%)
after the first year. One patient required surgery for an
anastomotic false aneurysm. A woven polyester fiber
(Dacron) patch was used in this patient’s initial CEA.
Six-month duplex scan results. Follow-up ICA
duplex scans within the first 6 months revealed normal
results after 364 (96%) CEAs. There were 14 mild recur-
rent ICA stenoses < 60% (4%) and two moderate recurrent
ICA stenoses between 60% and 79% (0.5%). There were
no severe recurrent ICA stenoses > 80%. Completion
studies showed no abnormalities in patients with recurrent
ICA stenosis. ECA recurrent stenoses included 7 mild, 15
moderate, and 9 severe restenoses.
Of the 14 patients with mild restenosis, one regressed
to normal within the first postoperative month. The two
patients with moderate stenosis had their duplex examina-
tions at 189 days and 177 days, postoperatively. Both
patients with moderate restenosis previously had duplex
examinations with normal findings, one at 18 days and the
other at both 40 and 68 days postoperatively. A comple-
tion study showed no abnormalities in either patient, and
neither patient underwent an intraoperative revision.
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Neither patient had symptoms. No patient required surgi-
cal intervention for restenosis within the first 6 months.
One-year duplex scan results. Follow-up duplex
scans within the first year were available after 222 CEAs
(58%). The results were normal after 202 CEAs (91%).
Twelve patients had mild restenosis < 60% (5%). Six of
these were new stenoses not seen in the first 6 months.
Five of these were stable stenoses seen in the initial 
follow-up duplex scan. Seven patients had moderate
restenosis of 60% to 79% (3%). One patient with moder-
ate restenosis at 186 days postoperatively regressed to
mild restenosis on follow-up duplex scan at 396 days. Five
of these were new stenoses not seen on the initial follow-
up duplex scan. Two of these were stable stenoses seen on
the initial follow-up duplex scan.
Two patients had severe restenosis > 80% on duplex
scan (1%). In one of these patients, normal duplex scan
results had previously been found at 26 and 229 days post-
operatively. The patient had a mild stroke, and at this time,
403 days postoperatively, stenosis was noted to be > 80%.
A redo CEA was performed on this patient. The patient
had a TIA 1 month after this second CEA; however, con-
scientious follow-up duplex examinations have shown no
restenosis at 1 month, 6 months, and 1 year. The second
patient was noted to have no restenosis at 77 days postop-
eratively. A follow-up duplex scan at 239 days postopera-
tively noted > 80% stenosis. The patient was symptom
free, and we chose to follow up with serial duplex scans.
This patient was evaluated for reoperation, and on the
basis of the patient’s current medical condition, surgical
intervention was not performed at this time. At 297 and
394 days there was no change in stenosis. At 2 years, how-
ever, the stenosis had regressed to moderate and remained
stable for 3 years. The patient did have a TIA after 2 years
postoperatively. There were no total occlusions on duplex
scan at 1 year.
DISCUSSION
CEA is the accepted method of preventing strokes in
patients with both symptomatic and asymptomatic carotid
stenosis. Our data support this finding with a 1% perioper-
ative stroke rate and a 3% long-term ipsilateral stroke rate.
Duplex scanning surveillance is the method of choice
for following restenosis rates after CEA. However, the
precise timing and frequency of follow-up duplex exami-
nation remain controversial. Duplex surveillance within
the first 1 to 2 months has been recommended by multi-
ple authors.10,11 The value of this first duplex scan in con-
junction with an intraoperative completion study had not
been previously fully accessed. For some authors, the need
for early postoperative duplex scan may be based on the
lack of intraoperative completion study. In other cases,
early postoperative duplex study has been performed
despite intraoperative completion studies.
Duplex surveillance within the first 6 months postoper-
atively in patients with intraoperative completion studies was
performed in 378 CEA cases over a 10-year period. We
excluded 264 patients who underwent CEAs because of a
lack of duplex surveillance within the first 6 months. We
found a 6% technical error rate (3% ICA and 3% ECA),
which was remedied by immediate revision. In all 378 cases,
the patient left the operating room without significant lesion
on the completion study. Restenosis of the ICA within the
first 6 months occurred in 4.5% of patients. A total of 4%
were mild with < 60% stenosis, and 0.5% were moderate
with 60% to 79% stenosis. No severe ICA restenosis > 80%
occurred within the first 6-month period, and only 1%
occurred at the first-year duplex scan. Recurrent stenosis has
been reported at levels from 4% to 19% of patients within the
first 2 years postoperatively.12 With the aid of the intraoper-
ative completion study, our observed restenosis was 4.5%
within the first 6 months. Thus, the completion study has
minimized our restenosis rate.
Neointimal hyperplasia has been established as the
cause for restenosis within the first 2 years.12,13 This
restenosis has been shown to mostly follow a benign
course with regression of the lesion in many cases.12,14,15
Mild and moderate restenosis has been shown to be
benign. Only in cases of severe asymptomatic stenosis 
(≥ 80%) is consideration for reoperation necessary.12 In
our experience, there were no cases of severe stenosis
within the first 6 months after CEA with intraoperative
completion study. No patient required reoperation within
the first 6 months for restenosis. Duplex scan results did
not alter our treatment of patients within the first 6
months. Thus, we found no benefit to duplex surveillance
within the first 6 months after CEA with intraoperative
completion study and only a 1% yield at 1 year. Of the 1%
severe stenosis, 0.5% were symptomatic and thus received
a duplex scan, whereas 0.5% were asymptomatic and found
on duplex scan surveillance.
Symptoms and future stroke are higher in patients
with ≥ 80% restenosis. Progression of lesions with 50% to
75% restenosis has been reported as high as 20% within 5
years of surgery.1 Further studies show a persistent
increase in restenosis rates to 13% and 23% at 5 and 10
years postoperatively.8 Thus, although our study suggests
that duplex scan surveillance within the first 6 months is
not necessary, the recommendation of surveillance at 1
year and then yearly thereafter for those patients with 
> 50% restenosis is still valid.8
ECA restenosis was noted in 31 cases (8%). This
included 7 mild, 15 moderate, and 9 severe restenoses.
This higher incidence of ECA restenosis may be due to the
fact that limited eversion endarterectomy, rather than
open technique, is usually used for these plaques. The
ramifications of ECA restenosis have not been studied,
and thus only speculation from anecdotal incidences
exists.
Postoperative stroke and restenosis have been associ-
ated with CEA with technical errors and may be as much
as three times as high as in CEAs without hemodynamic
compromise.5 Intraoperative completion studies have
become the standard for attaining a quality closure with-
out technical errors. For many years completion angiogra-
phy has been the technique of choice, but recently atten-
tion has focused on intraoperative duplex scans. The
benefits of duplex ultrasound scan include decreased risk
of renal dysfunction, air embolus, and dissection.3,15-17
Intraoperative duplex completion study has been estab-
lished as a reliable method to evaluate intraoperative tech-
nique and minimize technical error by allowing for
immediate revision during the same operation.9,10 In
operating rooms where expeditious service by experienced
personnel is available, duplex scanning can replace angiog-
raphy. As is the case with a number of centers, we have
tried to switch to intraoperative scanning, but have been
unable to obtain efficient service and have continued to
rely on angiography.
Overall, the findings of this study challenge the need
for early surveillance. After CEA with normal completion
study results, we advocate that duplex surveillance should
begin at 1 year. The need for further follow-up is still
somewhat controversial. In those patients without
restenosis, follow-up duplex scan has been recommended
at intervals of 1 to 2 years.5 However, if restenosis is noted
to be > 60%, biannual to annual duplex surveillance is
required to evaluate for progression.
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DISCUSSION
Dr C. Pross. Thank you Dr Raker, for your insightful and
kind comments. In response to your question, as far as
antiplatelets are concerned, aspirin was used in 80% of the patients
preoperatively and following that. It was not used in many emer-
gent cases for obvious reasons in patients with contraindications.
Initially, some of these patients were very early and thus in the
randomized trial to evaluate aspirin’s use, and some of them were
randomized to be without aspirin.
In emergent patients undergoing carotid endarterectomy,
many of them were on heparin preoperatively, and we also utilize
heparin within the operating room, and we did not reverse it.
Persantine was used early on in some of the studies. We don’t use
that at this point and tyclid in a very few number.
As far as your second question and how we evaluated the
intraoperative angiograms, we do use fluoro, but we minimize
how much dye is injected at the same time to prevent complica-
tion from that. We have pretty much established Bandyk’s sug-
gestions that include that we would revise a flap greater than 2
mm or stenosis > 20%.
As far as the ECA is concerned, we do not cross-clamp that,
and we choose to evaluate under fluoro the entire operative area
including the external carotid. Two percent of revision were for
major external carotid flaws. I believe that answers your questions.
Dr Richard Treiman (Los Angeles, Calif). Would the pres-
ence of a significant sounding bruit—we can discuss what “sig-
nificant sounding” sounds like—influence your recommendation
not to do a follow-up study within the first year?
Dr Pross. I think you probably would. Whether that’s based
on scientific data or emotions, though, I’m not certain. I think
that can be normal following carotid endarterectomy in any case.
However, especially with litigation these day, I think I would, yes.
Dr William Krupski (Denver, Colo). Dr Pross, I have a ques-
tion. What was the percent of carotid patching that you per-
formed, and was there any change over this 10-year interval in the
number of patches you applied because it seems in our practice
that we are using patching more and more liberally and seeing
restenosis less and less?
Dr Pross. We patched in 83%. And yes, in fact, if you go back
to the earlier days, it was less. I don’t have the exact number per
year, but there was a definite increase over the time period. Some
of that may be due to some changing viewpoints and changing
physicians during that time.
Dr Hugh Gelabert. Just in answering your question a little bit
more fully, Dr Krupski, several years ago Dr Moore and I
reviewed a series of patched and nonpatched patients.
Interestingly enough there was really no benefit in our review to
the patch.
Despite that, we have actually, Dr Moore and I and the rest
of the group, advanced forward into an era of patching most cases
when we have an inkling of a doubt, specifically small arteries,
women, patients who are smoking, patients who have hypercho-
lesterolemia, any of the significant risk factors so that, as Dr Pross
mentioned, at this stage we’re probably patching a good 80% to
85% of our patients, maybe even more.
Dr Kaj Johansen (Seattle, Wash). I infer that your carotid
endarterectomies were performed by what we in our group con-
sider the obsolete method, which is the longitudinal carotid arte-
riotomy. For the past 4 years my associate and I have performed
over 200 carotid endarterectomies by the transection eversion
technique commonly performed in Europe, rarely performed in
North America, at least to this point. Data suggest that the pro-
cedure takes slightly less time but most important, appears to
have a lower recurrence rate.
My questions, therefore, are number one, what was your
technique, and have you done this transection eversion tech-
nique?
Second, if I told you that for the past 10 years we have per-
formed no completion studies at all and have a recurrent carotid
stenosis rate of less than 5%, would you give me your response
including your thoughts about the medicolegal issues that you
raise?
Dr Pross. Well, a couple of things. To start with your first
question, yes, we did do it in the standard longitudinal manner.
As far as the eversion technique is concerned, the only thing that
I’ve heard really against it is the fact that it can be difficult getting
high enough with it, but otherwise, I think it’s more because it’s
just something that our attendings don’t do. They choose not to.
As far as your number of 5%, I would have to question you
on the way that you monitored that. It’s been shown that if you
just look for symptomatic, it will be much lower, and I don’t
know how you evaluated for that.
As far as the intraoperative completion study, if you have such
good results I have to conclude that maybe you don’t need that.
However, maybe you could perfect that even better and have the
half range that we’ve heard before of 2.5.
Dr Eugene Strandness (Seattle, Wash). I’m a little bit con-
cerned about the contralateral carotid. Are you telling me you
don’t follow the contralateral carotid by duplex? If you have
somebody with a moderate lesion, do you follow them at all or
just wait until they have an event?
Dr Pross. No. Actually, we do follow that relatively closely,
but in the age of cost containment we quite regularly will perform
a duplex on one side without the other, thus making it a little bit
cheaper, I guess, in the long run.
